🔗 Share this article

While the US continues making historic changes to its vaccination recommendations, one figure has emerged unexpectedly: Tracy Beth Høeg, a US-based sports physician and epidemiologist who rose to prominence by expressing skepticism about Covid shots throughout the pandemic and has zeroed in on alleged fatalities after Covid immunization in her short position at the US Food and Drug Administration (FDA).

Scheduled Changes to Childhood Vaccine Schedule

Agency leaders planned to unveil sweeping changes to the childhood vaccine schedule recently, aligning the US with the Danish immunization schedule, sources say – a significant shift that would place the US at odds with much of the world with insufficient data for improved outcomes. The planned update has been postponed until the new year.

Rather than the top vaccines chief, Høeg is listed to present at the meeting. She was newly appointed acting director of the FDA’s drug evaluation center, the fifth individual to head the center this year.

Consolidating Power at the Agency

The acting appointment may indicate a tighter collaboration between the pharmaceutical and vaccine divisions as Dr. Høeg and Prasad consolidate power at the agency – and it signals a increased emphasis upon rolling back previously authorized vaccines at the FDA.

Høeg has repeatedly called for discontinuing certain childhood shot schedules in the US in order to be more like Denmark's approach, a nation with nationalized medicine and a population approximately the size of Wisconsin’s.

To date public appearances, she has kept her attention on vaccines – typically the domain of Dr. Prasad, head of the FDA’s Center for Biologics Evaluation and Research (CBER) – as opposed to pharmaceutical oversight.

Doubts Over Qualifications

Høeg has little discernible experience in drug development, regulation or leadership, which has been customary for past leaders of the biologics center. She has been employed at the FDA as a top consultant to the agency head and CBER since March.

“She appears not to have the requisite experience” for overseeing the CDER, stated Jonathan Howard. “She lacks experience running a scientific study. She lacks experience in managing a major agency. She has no expertise in pharmaceutical oversight.”

Former commissioners of CBER would “be deeply familiar with laws and regulations and the research of medication creation”, said Dr. Janet Woodcock. “Clearly, she doesn’t have the kind of background that former directors who ran CBER have had.”

CDER has an enormous range of responsibilities at the agency, she emphasized.

“Many people just pays attention on the new drug program, but the off-patent medication office authorizes thousands of generic drugs. There is also a biosimilars division, OTC medication office and so forth, and every single one have to be supervised,” Woodcock said. “The area you neglect, that is precisely what that I always told people is going to cause problems.”

There is also, a significant management component to the role, which oversees more than 5,000 staff members. “It’s a huge management job, if you perform it correctly,” Woodcock said.

Response and Disputed Initiatives

When asked about inquiries about Dr. Høeg's fitness for the role and whether this assignment represents greater collaboration among FDA leaders on vaccines, a press secretary said that the “questions are based on flawed premises”.

“This background matches the duties of her position,” the official said, noting the time Høeg spent advising the FDA commissioner on “medication safety and regulatory science, including predictive safety algorithms and shot safety tracking”.

As the temporary head, Høeg assumes responsibility for the agency head's controversial priority voucher program, a controversial one-day drug-approval program that apparently worried her predecessors. “By what process are these medications being picked for this expedited pathway? Who takes the decisions?” Dr. Howard said. “There’s a lot of lack of transparency happening at the FDA right now.”

Broadly speaking, he remarked, “the FDA seems to be moving towards more relaxed regulations of most medications, aside from vaccines.”

Established History on Immunizations

Concerning vaccines, Høeg has a more established, if problematic, track record, Howard observe. She released a analysis using unverified public submissions to determine the rate of myocarditis after COVID-19 immunization. She consulted for the Florida top health official Joseph Ladapo, who was said to have altered data to suggest COVID-19 vaccines are more dangerous than they are.

Among her “desired changes” for the new administration featured revising regulations for novel immunizations and discontinuing “optional” immunizations, she said after the election on a online show. At the agency, Dr. Høeg has allegedly proposed excluding teenage boys from obtaining Covid vaccinations.

“She is an complete dogmatist who commences with her beliefs and works backwards to retrofit the evidence in a highly misleading, fraudulent fashion,” Dr. Howard said.

Consolidating Power and a “Campaign of Retribution”

Dr. Høeg became part of fellow contrarians, {like|